SCHEMBL8933379

SCHEMBL8933379

CN(C)N1CSC(=CCc2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.40
TSHR P16473 4/20 0.40
GAA P10253 3/20 0.40
LMNA P02545 3/20 0.40
MAPT P10636 4/20 0.38
MAPK1 P28482 3/20 0.38
CYP1A2 P05177 3/20 0.38
MEN1 O00255 2/20 0.38
CYP3A4 P08684 2/20 0.38
BLM P54132 2/20 0.38
KMT2A Q03164 2/20 0.38
ATM Q13315 2/20 0.38
HIF1A Q16665 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
USP2 O75604 1/20 0.38
CYP2D6 P10635 1/20 0.38
TDP1 Q9NUW8 2/20 0.37
KDM4E B2RXH2 5/20 0.36
PTGS2 P35354 3/20 0.36
PTGS1 P23219 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9029562 1.00 ALDH1A1 (0.40) ALDH1A1TSHRGAALMNAMAPT
SCHEMBL8895700 0.84 ALDH1A1 (0.42) ALDH1A1TSHRGAALMNAMAPT
SCHEMBL2746044 0.81 PTGS2 (0.52) ALDH1A1GAACYP1A2MEN1KMT2A
SCHEMBL2746042 0.81 PTGS2 (0.52) ALDH1A1GAACYP1A2MEN1KMT2A
SCHEMBL8991929 0.75 PTGS2 (0.45) ALDH1A1GAALMNAMAPTCYP1A2
SCHEMBL9028884 0.75 ALDH1A1 (0.40) ALDH1A1TSHRGAALMNAMAPT
SCHEMBL8894724 0.75 PTGS2 (0.45) ALDH1A1GAALMNAMAPTCYP1A2
SCHEMBL8992161 0.75 ALDH1A1 (0.40) ALDH1A1TSHRGAALMNAMAPT
SCHEMBL6430738 0.74 PTGS2 (0.45) ALDH1A1GAACYP1A2MEN1KMT2A
SCHEMBL6430736 0.74 PTGS2 (0.45) ALDH1A1GAACYP1A2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996022772-A1 METHOD FOR TREATING MULTIPLE SCLEROSIS ELI LILLY AND COMPANY (US) 1996-08-01 WO disclosed
EP-0722729-A2 Aryl-substituted rhodanines for treating multiple sclerosis ELI LILLY AND COMPANY (US) 1996-07-24 EP disclosed
EP-0391644-B1 Aryl-substituted rhodanine derivatives LILLY CO ELI (US) 1996-06-19 EP disclosed
US-5356917-A Antiischemic, antiinflammatory, antiarthritic agents, treat-ment of dystrophic mammals ELI LILLY AND COMPANY (US) 1994-10-18 US disclosed
US-5158966-A Aryl-substituted rhodanine derivatives THE UNIVERSITY OF COLORADO FOUNDATION, INC. (US) 1992-10-27 US disclosed
EP-0500337-A1 Composition containing aryl-substituted rhodanine derivatives for the treatment of type I diabetes UNIVERSITY OF COLORADO FOUNDATION, INC. (US) 1992-08-26 EP disclosed
EP-0391644-A2 Aryl-substituted rhodanine derivatives ELI LILLY AND COMPANY (US) 1990-10-10 EP disclosed